Skip to main content

Table 3 Risk factor analysis for in-hospital mortality of ECMO patients

From: Cross-sectional study for the clinical application of extracorporeal membrane oxygenation in Mainland China, 2018

Factors

All

OR

95% CI

P

Type (Ref = VA)

 VV

0.95

0.75

1.19

0.6431

Age (Ref = 0–13)

 14–20

1.11

0.62

1.98

0.7255

 21–30

0.84

0.52

1.35

0.4699

 31–40

0.80

0.50

1.27

0.3469

 41–50

0.87

0.56

1.34

0.5280

 51–60

1.13

0.74

1.71

0.5823

 61–70

1.12

0.74

1.70

0.5782

  > 71

1.61

1.01

2.55

0.0452

Sex (Ref = male)

 Female

0.80

0.65

0.99

0.0400

GDP (Ref = high)

 Middle

0.72

0.56

0.93

0.0110

 Low

1.19

0.86

1.66

0.3017

Season (Ref = spring)

 Summer

1.35

1.01

1.81

0.0420

 Autumn

0.92

0.69

1.22

0.5658

 Winter

1.10

0.84

1.46

0.4858

Diagnosis at discharge

 Infectious disease

1.01

0.79

1.29

0.9584

 Blood system disease

1.29

1.01

1.65

0.0413

 Endocrine disease

1.18

0.96

1.46

0.1221

 CNS disease

1.85

1.40

2.43

< 0.0001

 Circulatory disease

 Respiratory disease

 Digestive disease

1.10

0.88

1.38

0.3953

 Urogenital diseases

1.04

0.83

1.31

0.7348

Congenital malformations

1.59

1.08

2.33

0.0180

Injury and poisoning

1.12

0.83

1.52

0.4607

  1. ECMO extracorporeal membrane oxygenation, VV veno-venous, VA veno-arterial, OR odd ration, 95%CI 95% confidence interval, GDP gross domestic product, CNS disease central nervous disease